Drug project high-priority medications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
==WikiDoc Drug Project — High-Priority Medications== | ==WikiDoc Drug Project — High-Priority Medications== | ||
* Template here: [[Drug page template]] | *Template here: [[Drug page template]] | ||
* Example here: [[Clopidogrel]] | *Example here: [[Clopidogrel]] | ||
* FDA package insert here: [https://dailymed.nlm.nih.gov/dailymed/ DailyMed] | *FDA package insert here: [https://dailymed.nlm.nih.gov/dailymed/ DailyMed] | ||
==List of high-priority medications== | ==List of high-priority medications== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|'''Year''' | | align="center" style="background:#f0f0f0;" |'''Year''' | ||
| align="center" style="background:#f0f0f0;"|'''No.''' | | align="center" style="background:#f0f0f0;" |'''No.''' | ||
| align="center" style="background:#f0f0f0;"|'''Brand Name''' | | align="center" style="background:#f0f0f0;" |'''Brand Name''' | ||
| align="center" style="background:#f0f0f0;"|'''Active Ingredient''' | | align="center" style="background:#f0f0f0;" |'''Active Ingredient''' | ||
| align="center" style="background:#f0f0f0;"|'''Page Link''' | | align="center" style="background:#f0f0f0;" |'''Page Link''' | ||
| align="center" style="background:#f0f0f0;"|'''DailyMed Search''' | | align="center" style="background:#f0f0f0;" |'''DailyMed Search''' | ||
| align="center" style="background:#f0f0f0;"|'''Approval Date''' | | align="center" style="background:#f0f0f0;" |'''Approval Date''' | ||
|'''Status''' | |||
|'''Author''' | |||
|- | |- | ||
| 2019||12||Polivy||Polatuzumab vedotin-piiq||[[Polatuzumab vedotin-piiq]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Polivy Polivy]||6/10/2019 | |2019||12||Polivy||Polatuzumab vedotin-piiq||[[Polatuzumab vedotin-piiq]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Polivy Polivy]||6/10/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||11||Piqray||Alpelisib||[[Alpelisib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Piqray Piqray]||5/24/2019 | |2019||11||Piqray||Alpelisib||[[Alpelisib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Piqray Piqray]||5/24/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||10||Vyndaqel||Tafamidis meglumine||[[Tafamidis meglumine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vyndaqel Vyndaqel]||5/3/2019 | |2019||10||Vyndaqel||Tafamidis meglumine||[[Tafamidis meglumine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vyndaqel Vyndaqel]||5/3/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||9||Skyrizi||Risankizumab||[[Risankizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Skyrizi Skyrizi]||4/23/2019 | |2019||9||Skyrizi||Risankizumab||[[Risankizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Skyrizi Skyrizi]||4/23/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Balversa Balversa]||4/12/2019 | |2019||8||Balversa||Erdafitinib||[[Erdafitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Balversa Balversa]||4/12/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||7||Evenity||Romosozumab||[[Romosozumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Evenity Evenity]||4/9/2019 | |2019||7||Evenity||Romosozumab||[[Romosozumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Evenity Evenity]||4/9/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||6||Mayzent||Siponimod||[[Siponimod]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mayzent Mayzent]||3/26/2019 | |2019||6||Mayzent||Siponimod||[[Siponimod]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mayzent Mayzent]||3/26/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||5||Sunosi||Solriamfetol||[[Solriamfetol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Sunosi Sunosi]||3/20/2019 | |2019||5||Sunosi||Solriamfetol||[[Solriamfetol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Sunosi Sunosi]||3/20/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||4||Zulresso||Brexanolone||[[Brexanolone]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Zulresso Zulresso]||3/19/2019 | |2019||4||Zulresso||Brexanolone||[[Brexanolone]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Zulresso Zulresso]||3/19/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||3||Egaten||Triclabendazole||[[Triclabendazole]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Egaten Egaten]||2/13/2019 | |2019||3||Egaten||Triclabendazole||[[Triclabendazole]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Egaten Egaten]||2/13/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||2||Cablivi||Caplacizumab||[[Caplacizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Cablivi Cablivi]||2/6/2019 | |2019||2||Cablivi||Caplacizumab||[[Caplacizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Cablivi Cablivi]||2/6/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2019||1||Jeuveau||prabotulinum toxin type a powder||[[prabotulinum toxin type a powder]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Jeuveau Jeuveau]||2/1/2019 | |2019||1||Jeuveau||prabotulinum toxin type a powder||[[prabotulinum toxin type a powder]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Jeuveau Jeuveau]||2/1/2019 | ||
| | |||
| | |||
|- | |- | ||
| 2018||59||Ultomiris||Ravulizumab||[[Ravulizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ultomiris Ultomiris]||12/21/2018 | |2018||59||Ultomiris||Ravulizumab||[[Ravulizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ultomiris Ultomiris]||12/21/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||58||Elzonris||Tagraxofusp-erzs||[[Tagraxofusp-erzs]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Elzonris Elzonris]||12/21/2018 | |2018||58||Elzonris||Tagraxofusp-erzs||[[Tagraxofusp-erzs]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Elzonris Elzonris]||12/21/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||57||Asparlas||Calaspargase pegol-mknl||[[Calaspargase pegol-mknl]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Asparlas Asparlas]||12/20/2018 | |2018||57||Asparlas||Calaspargase pegol-mknl||[[Calaspargase pegol-mknl]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Asparlas Asparlas]||12/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||56||Motegrity||Prucalopride||[[Prucalopride]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Motegrity Motegrity]||12/14/2018 | |2018||56||Motegrity||Prucalopride||[[Prucalopride]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Motegrity Motegrity]||12/14/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||55||Xospata||Gilteritinib||[[Gilteritinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xospata Xospata]||11/28/2018 | |2018||55||Xospata||Gilteritinib||[[Gilteritinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xospata Xospata]||11/28/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||54||Firdapse||Amifampridine||[[Amifampridine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Firdapse Firdapse]||11/28/2028 | |2018||54||Firdapse||Amifampridine||[[Amifampridine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Firdapse Firdapse]||11/28/2028 | ||
| | |||
| | |||
|- | |- | ||
| 2018||53||Vitrakvi||Larotrectinib||[[Larotrectinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vitrakvi Vitrakvi]||11/26/2018 | |2018||53||Vitrakvi||Larotrectinib||[[Larotrectinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vitrakvi Vitrakvi]||11/26/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||52||Daurismo||Glasdegib||[[Glasdegib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Daurismo Daurismo]||11/21/2018 | |2018||52||Daurismo||Glasdegib||[[Glasdegib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Daurismo Daurismo]||11/21/2018 | ||
|Need review | |||
|Bhavya | |||
|- | |- | ||
| 2018||51||Gamifant||Emapalumab-lzsgemapalumab-lzsg||[[Emapalumab-lzsgemapalumab-lzsg]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Gamifant Gamifant]||11/20/2018 | |2018||51||Gamifant||Emapalumab-lzsgemapalumab-lzsg||[[Emapalumab-lzsgemapalumab-lzsg]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Gamifant Gamifant]||11/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||50||Aemcolo||Rifamycin||[[Rifamycin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aemcolo Aemcolo]||11/16/2018 | |2018||50||Aemcolo||Rifamycin||[[Rifamycin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aemcolo Aemcolo]||11/16/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||49||Yupelri||Revefenacin||[[Revefenacin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Yupelri Yupelri]||11/9/2018 | |2018||49||Yupelri||Revefenacin||[[Revefenacin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Yupelri Yupelri]||11/9/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||48||Lorbrena||Lorlatinib||[[Lorlatinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lorbrena Lorbrena]||11/2/2018 | |2018||48||Lorbrena||Lorlatinib||[[Lorlatinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lorbrena Lorbrena]||11/2/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||47||Xofluza||Baloxavir marboxil||[[Baloxavir marboxil]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xofluza Xofluza]||10/24/2018 | |2018||47||Xofluza||Baloxavir marboxil||[[Baloxavir marboxil]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xofluza Xofluza]||10/24/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||46||Talzenna||Talazoparib||[[Talazoparib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Talzenna Talzenna]||10/16/2018 | |2018||46||Talzenna||Talazoparib||[[Talazoparib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Talzenna Talzenna]||10/16/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||45||Tegsedi||Inotersen||[[Inotersen]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tegsedi Tegsedi]||10/5/2018 | |2018||45||Tegsedi||Inotersen||[[Inotersen]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tegsedi Tegsedi]||10/5/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||44||Revcovi||Elapegademase-lvlr||[[Elapegademase-lvlr]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Revcovi Revcovi]||10/5/2018 | |2018||44||Revcovi||Elapegademase-lvlr||[[Elapegademase-lvlr]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Revcovi Revcovi]||10/5/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||43||Nuzyra||Omadacycline||[[Omadacycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Nuzyra Nuzyra]||10/2/2018 | |2018||43||Nuzyra||Omadacycline||[[Omadacycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Nuzyra Nuzyra]||10/2/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||42||Seysara||Sarecycline||[[Sarecycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Seysara Seysara]||10/1/2018 | |2018||42||Seysara||Sarecycline||[[Sarecycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Seysara Seysara]||10/1/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||41||Libtayo||Cemiplimab-rwlc||[[Cemiplimab-rwlc]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Libtayo Libtayo]||9/28/2018 | |2018||41||Libtayo||Cemiplimab-rwlc||[[Cemiplimab-rwlc]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Libtayo Libtayo]||9/28/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||40||Vizimpro||Dacomitinib||[[Dacomitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vizimpro Vizimpro]||9/27/2018 | |2018||40||Vizimpro||Dacomitinib||[[Dacomitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Vizimpro Vizimpro]||9/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||39||Emgality||Galcanezumab-gnlm||[[Galcanezumab-gnlm]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Emgality Emgality]||9/27/2018 | |2018||39||Emgality||Galcanezumab-gnlm||[[Galcanezumab-gnlm]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Emgality Emgality]||9/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||38||Copiktra||Duvelisib||[[Duvelisib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Copiktra Copiktra]||9/24/2018 | |2018||38||Copiktra||Duvelisib||[[Duvelisib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Copiktra Copiktra]||9/24/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||37||Ajovy||Fremanezumab-vfrm||[[Fremanezumab-vfrm]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ajovy Ajovy]||9/14/2018 | |2018||37||Ajovy||Fremanezumab-vfrm||[[Fremanezumab-vfrm]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ajovy Ajovy]||9/14/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||36||Lumoxiti||Moxetumomab pasudotox-tdfk||[[Moxetumomab pasudotox-tdfk]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lumoxiti Lumoxiti]||9/13/2018 | |2018||36||Lumoxiti||Moxetumomab pasudotox-tdfk||[[Moxetumomab pasudotox-tdfk]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lumoxiti Lumoxiti]||9/13/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||35||Pifeltro||Doravirine||[[Doravirine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Pifeltro Pifeltro]||8/30/2018 | |2018||35||Pifeltro||Doravirine||[[Doravirine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Pifeltro Pifeltro]||8/30/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||34||Xerava||Eravacycline||[[Eravacycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xerava Xerava]||8/27/2018 | |2018||34||Xerava||Eravacycline||[[Eravacycline]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Xerava Xerava]||8/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||33||Takhzyro||Lanadelumab||[[Lanadelumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Takhzyro Takhzyro]||8/23/2018 | |2018||33||Takhzyro||Lanadelumab||[[Lanadelumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Takhzyro Takhzyro]||8/23/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||32||Oxervate||Cenegermin-bkbj||[[Cenegermin-bkbj]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Oxervate Oxervate]||8/22/2018 | |2018||32||Oxervate||Cenegermin-bkbj||[[Cenegermin-bkbj]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Oxervate Oxervate]||8/22/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||31||Diacomit||Stiripentol||[[Stiripentol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Diacomit Diacomit]||8/20/2018 | |2018||31||Diacomit||Stiripentol||[[Stiripentol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Diacomit Diacomit]||8/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||30||Galafold||Migalastat||[[Migalastat]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Galafold Galafold]||8/10/2018 | |2018||30||Galafold||Migalastat||[[Migalastat]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Galafold Galafold]||8/10/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||29||Annovera||Segesterone acetate and ethinyl estradiol vaginal system||[[Segesterone acetate and ethinyl estradiol vaginal system]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Annovera Annovera]||8/10/2018 | |2018||29||Annovera||Segesterone acetate and ethinyl estradiol vaginal system||[[Segesterone acetate and ethinyl estradiol vaginal system]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Annovera Annovera]||8/10/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||28||Onpattro||Patisiran||[[Patisiran]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Onpattro Onpattro]||8/10/2018 | |2018||28||Onpattro||Patisiran||[[Patisiran]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Onpattro Onpattro]||8/10/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||27||Poteligeo||Mogamulizumab||[[Mogamulizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Poteligeo Poteligeo]||8/8/2018 | |2018||27||Poteligeo||Mogamulizumab||[[Mogamulizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Poteligeo Poteligeo]||8/8/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||26||Mulpleta||Lusutrombopag||[[Lusutrombopag]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mulpleta Mulpleta]||7/31/2018 | |2018||26||Mulpleta||Lusutrombopag||[[Lusutrombopag]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mulpleta Mulpleta]||7/31/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||25||Omegaven||Fish oil triglycerides||[[Fish oil triglycerides]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Omegaven Omegaven]||7/27/2018 | |2018||25||Omegaven||Fish oil triglycerides||[[Fish oil triglycerides]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Omegaven Omegaven]||7/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||24||Orilissa||Elagolix||[[Elagolix]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Orilissa Orilissa]||7/23/2018 | |2018||24||Orilissa||Elagolix||[[Elagolix]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Orilissa Orilissa]||7/23/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||23||Krintafel||Tafenoquine||[[Tafenoquine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Krintafel Krintafel]||7/20/2018 | |2018||23||Krintafel||Tafenoquine||[[Tafenoquine]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Krintafel Krintafel]||7/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||22||Tibsovo||Ivosidenib||[[Ivosidenib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tibsovo Tibsovo]||7/20/2018 | |2018||22||Tibsovo||Ivosidenib||[[Ivosidenib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tibsovo Tibsovo]||7/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||21||TPOXX||Tecovirimat||[[Tecovirimat]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TPOXX TPOXX]||7/13/2018 | |2018||21||TPOXX||Tecovirimat||[[Tecovirimat]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TPOXX TPOXX]||7/13/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||20||Braftovi||Encorafenib||[[Encorafenib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Braftovi Braftovi]||6/27/2018 | |2018||20||Braftovi||Encorafenib||[[Encorafenib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Braftovi Braftovi]||6/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||19||Mektovi||Binimetinib||[[Binimetinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mektovi Mektovi]||6/27/2018 | |2018||19||Mektovi||Binimetinib||[[Binimetinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Mektovi Mektovi]||6/27/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||18||Zemdri||Plazomicin||[[Plazomicin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Zemdri Zemdri]||6/25/2018 | |2018||18||Zemdri||Plazomicin||[[Plazomicin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Zemdri Zemdri]||6/25/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||17||Epidioloex||Cannabidiol||[[Cannabidiol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Epidioloex Epidioloex]||6/25/2018 | |2018||17||Epidioloex||Cannabidiol||[[Cannabidiol]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Epidioloex Epidioloex]||6/25/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||16||Moxidectin||Moxidectin||[[Moxidectin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Moxidectin Moxidectin]||6/13/2018 | |2018||16||Moxidectin||Moxidectin||[[Moxidectin]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Moxidectin Moxidectin]||6/13/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||15||Olumiant||Baricitinib||[[Baricitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Olumiant Olumiant]||5/31/2018 | |2018||15||Olumiant||Baricitinib||[[Baricitinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Olumiant Olumiant]||5/31/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||14||Palynziq||Pegvaliase-pqpz||[[Pegvaliase-pqpz]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Palynziq Palynziq]||5/24/2018 | |2018||14||Palynziq||Pegvaliase-pqpz||[[Pegvaliase-pqpz]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Palynziq Palynziq]||5/24/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||13||Doptelet||Avatrombopag||[[Avatrombopag]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Doptelet Doptelet]||5/21/2018 | |2018||13||Doptelet||Avatrombopag||[[Avatrombopag]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Doptelet Doptelet]||5/21/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||12||Lokelma||Sodium zirconium cyclosilicate||[[Sodium zirconium cyclosilicate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lokelma Lokelma]||5/18/2018 | |2018||12||Lokelma||Sodium zirconium cyclosilicate||[[Sodium zirconium cyclosilicate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lokelma Lokelma]||5/18/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||11||Aimovig||Erenumab-aooe||[[Erenumab-aooe]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aimovig Aimovig]||5/17/2018 | |2018||11||Aimovig||Erenumab-aooe||[[Erenumab-aooe]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Aimovig Aimovig]||5/17/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||10||Lucemyra||Lofexidine hydrochloride||[[Lofexidine hydrochloride]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lucemyra Lucemyra]||5/16/2018 | |2018||10||Lucemyra||Lofexidine hydrochloride||[[Lofexidine hydrochloride]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lucemyra Lucemyra]||5/16/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||9||Akynzeo||Fosnetupitant and palonosetron||[[Fosnetupitant and palonosetron]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Akynzeo Akynzeo]||4/19/2018 | |2018||9||Akynzeo||Fosnetupitant and palonosetron||[[Fosnetupitant and palonosetron]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Akynzeo Akynzeo]||4/19/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||8||Crysvita||Burosumab-twza||[[Burosumab-twza]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Crysvita Crysvita]||4/17/2018 | |2018||8||Crysvita||Burosumab-twza||[[Burosumab-twza]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Crysvita Crysvita]||4/17/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||7||Tavalisse||Fostamatinib||[[Fostamatinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tavalisse Tavalisse]||4/17/2018 | |2018||7||Tavalisse||Fostamatinib||[[Fostamatinib]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Tavalisse Tavalisse]||4/17/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||6||Ilumya||Tildrakizumab||[[Tildrakizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ilumya Ilumya]||3/20/2018 | |2018||6||Ilumya||Tildrakizumab||[[Tildrakizumab]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ilumya Ilumya]||3/20/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||5||Trogarzo||Ibalizumab-uiyk||[[Ibalizumab-uiyk]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Trogarzo Trogarzo]||3/6/2018 | |2018||5||Trogarzo||Ibalizumab-uiyk||[[Ibalizumab-uiyk]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Trogarzo Trogarzo]||3/6/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||4||Erleada||Apalutamide||[[Apalutamide]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Erleada Erleada]||2/14/2018 | |2018||4||Erleada||Apalutamide||[[Apalutamide]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Erleada Erleada]||2/14/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||3||Symdeko||Tezacaftor/ivacaftor||[[Tezacaftor/ivacaftor]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Symdeko Symdeko]||2/12/2018 | |2018||3||Symdeko||Tezacaftor/ivacaftor||[[Tezacaftor/ivacaftor]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Symdeko Symdeko]||2/12/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||2||Biktarvy||Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate||[[Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Biktarvy Biktarvy]||2/7/2018 | |2018||2||Biktarvy||Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate||[[Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Biktarvy Biktarvy]||2/7/2018 | ||
| | |||
| | |||
|- | |- | ||
| 2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lutathera Lutathera]||1/26/2018 | |2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lutathera Lutathera]||1/26/2018 | ||
| | |||
| | |||
|} | |} | ||
</div> | </div> | ||
Revision as of 17:12, 8 September 2020
WikiDoc Drug Project — High-Priority Medications
- Template here: Drug page template
- Example here: Clopidogrel
- FDA package insert here: DailyMed
List of high-priority medications
| Year | No. | Brand Name | Active Ingredient | Page Link | DailyMed Search | Approval Date | Status | Author |
| 2019 | 12 | Polivy | Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq | Polivy | 6/10/2019 | ||
| 2019 | 11 | Piqray | Alpelisib | Alpelisib | Piqray | 5/24/2019 | ||
| 2019 | 10 | Vyndaqel | Tafamidis meglumine | Tafamidis meglumine | Vyndaqel | 5/3/2019 | ||
| 2019 | 9 | Skyrizi | Risankizumab | Risankizumab | Skyrizi | 4/23/2019 | ||
| 2019 | 8 | Balversa | Erdafitinib | Erdafitinib | Balversa | 4/12/2019 | ||
| 2019 | 7 | Evenity | Romosozumab | Romosozumab | Evenity | 4/9/2019 | ||
| 2019 | 6 | Mayzent | Siponimod | Siponimod | Mayzent | 3/26/2019 | ||
| 2019 | 5 | Sunosi | Solriamfetol | Solriamfetol | Sunosi | 3/20/2019 | ||
| 2019 | 4 | Zulresso | Brexanolone | Brexanolone | Zulresso | 3/19/2019 | ||
| 2019 | 3 | Egaten | Triclabendazole | Triclabendazole | Egaten | 2/13/2019 | ||
| 2019 | 2 | Cablivi | Caplacizumab | Caplacizumab | Cablivi | 2/6/2019 | ||
| 2019 | 1 | Jeuveau | prabotulinum toxin type a powder | prabotulinum toxin type a powder | Jeuveau | 2/1/2019 | ||
| 2018 | 59 | Ultomiris | Ravulizumab | Ravulizumab | Ultomiris | 12/21/2018 | ||
| 2018 | 58 | Elzonris | Tagraxofusp-erzs | Tagraxofusp-erzs | Elzonris | 12/21/2018 | ||
| 2018 | 57 | Asparlas | Calaspargase pegol-mknl | Calaspargase pegol-mknl | Asparlas | 12/20/2018 | ||
| 2018 | 56 | Motegrity | Prucalopride | Prucalopride | Motegrity | 12/14/2018 | ||
| 2018 | 55 | Xospata | Gilteritinib | Gilteritinib | Xospata | 11/28/2018 | ||
| 2018 | 54 | Firdapse | Amifampridine | Amifampridine | Firdapse | 11/28/2028 | ||
| 2018 | 53 | Vitrakvi | Larotrectinib | Larotrectinib | Vitrakvi | 11/26/2018 | ||
| 2018 | 52 | Daurismo | Glasdegib | Glasdegib | Daurismo | 11/21/2018 | Need review | Bhavya |
| 2018 | 51 | Gamifant | Emapalumab-lzsgemapalumab-lzsg | Emapalumab-lzsgemapalumab-lzsg | Gamifant | 11/20/2018 | ||
| 2018 | 50 | Aemcolo | Rifamycin | Rifamycin | Aemcolo | 11/16/2018 | ||
| 2018 | 49 | Yupelri | Revefenacin | Revefenacin | Yupelri | 11/9/2018 | ||
| 2018 | 48 | Lorbrena | Lorlatinib | Lorlatinib | Lorbrena | 11/2/2018 | ||
| 2018 | 47 | Xofluza | Baloxavir marboxil | Baloxavir marboxil | Xofluza | 10/24/2018 | ||
| 2018 | 46 | Talzenna | Talazoparib | Talazoparib | Talzenna | 10/16/2018 | ||
| 2018 | 45 | Tegsedi | Inotersen | Inotersen | Tegsedi | 10/5/2018 | ||
| 2018 | 44 | Revcovi | Elapegademase-lvlr | Elapegademase-lvlr | Revcovi | 10/5/2018 | ||
| 2018 | 43 | Nuzyra | Omadacycline | Omadacycline | Nuzyra | 10/2/2018 | ||
| 2018 | 42 | Seysara | Sarecycline | Sarecycline | Seysara | 10/1/2018 | ||
| 2018 | 41 | Libtayo | Cemiplimab-rwlc | Cemiplimab-rwlc | Libtayo | 9/28/2018 | ||
| 2018 | 40 | Vizimpro | Dacomitinib | Dacomitinib | Vizimpro | 9/27/2018 | ||
| 2018 | 39 | Emgality | Galcanezumab-gnlm | Galcanezumab-gnlm | Emgality | 9/27/2018 | ||
| 2018 | 38 | Copiktra | Duvelisib | Duvelisib | Copiktra | 9/24/2018 | ||
| 2018 | 37 | Ajovy | Fremanezumab-vfrm | Fremanezumab-vfrm | Ajovy | 9/14/2018 | ||
| 2018 | 36 | Lumoxiti | Moxetumomab pasudotox-tdfk | Moxetumomab pasudotox-tdfk | Lumoxiti | 9/13/2018 | ||
| 2018 | 35 | Pifeltro | Doravirine | Doravirine | Pifeltro | 8/30/2018 | ||
| 2018 | 34 | Xerava | Eravacycline | Eravacycline | Xerava | 8/27/2018 | ||
| 2018 | 33 | Takhzyro | Lanadelumab | Lanadelumab | Takhzyro | 8/23/2018 | ||
| 2018 | 32 | Oxervate | Cenegermin-bkbj | Cenegermin-bkbj | Oxervate | 8/22/2018 | ||
| 2018 | 31 | Diacomit | Stiripentol | Stiripentol | Diacomit | 8/20/2018 | ||
| 2018 | 30 | Galafold | Migalastat | Migalastat | Galafold | 8/10/2018 | ||
| 2018 | 29 | Annovera | Segesterone acetate and ethinyl estradiol vaginal system | Segesterone acetate and ethinyl estradiol vaginal system | Annovera | 8/10/2018 | ||
| 2018 | 28 | Onpattro | Patisiran | Patisiran | Onpattro | 8/10/2018 | ||
| 2018 | 27 | Poteligeo | Mogamulizumab | Mogamulizumab | Poteligeo | 8/8/2018 | ||
| 2018 | 26 | Mulpleta | Lusutrombopag | Lusutrombopag | Mulpleta | 7/31/2018 | ||
| 2018 | 25 | Omegaven | Fish oil triglycerides | Fish oil triglycerides | Omegaven | 7/27/2018 | ||
| 2018 | 24 | Orilissa | Elagolix | Elagolix | Orilissa | 7/23/2018 | ||
| 2018 | 23 | Krintafel | Tafenoquine | Tafenoquine | Krintafel | 7/20/2018 | ||
| 2018 | 22 | Tibsovo | Ivosidenib | Ivosidenib | Tibsovo | 7/20/2018 | ||
| 2018 | 21 | TPOXX | Tecovirimat | Tecovirimat | TPOXX | 7/13/2018 | ||
| 2018 | 20 | Braftovi | Encorafenib | Encorafenib | Braftovi | 6/27/2018 | ||
| 2018 | 19 | Mektovi | Binimetinib | Binimetinib | Mektovi | 6/27/2018 | ||
| 2018 | 18 | Zemdri | Plazomicin | Plazomicin | Zemdri | 6/25/2018 | ||
| 2018 | 17 | Epidioloex | Cannabidiol | Cannabidiol | Epidioloex | 6/25/2018 | ||
| 2018 | 16 | Moxidectin | Moxidectin | Moxidectin | Moxidectin | 6/13/2018 | ||
| 2018 | 15 | Olumiant | Baricitinib | Baricitinib | Olumiant | 5/31/2018 | ||
| 2018 | 14 | Palynziq | Pegvaliase-pqpz | Pegvaliase-pqpz | Palynziq | 5/24/2018 | ||
| 2018 | 13 | Doptelet | Avatrombopag | Avatrombopag | Doptelet | 5/21/2018 | ||
| 2018 | 12 | Lokelma | Sodium zirconium cyclosilicate | Sodium zirconium cyclosilicate | Lokelma | 5/18/2018 | ||
| 2018 | 11 | Aimovig | Erenumab-aooe | Erenumab-aooe | Aimovig | 5/17/2018 | ||
| 2018 | 10 | Lucemyra | Lofexidine hydrochloride | Lofexidine hydrochloride | Lucemyra | 5/16/2018 | ||
| 2018 | 9 | Akynzeo | Fosnetupitant and palonosetron | Fosnetupitant and palonosetron | Akynzeo | 4/19/2018 | ||
| 2018 | 8 | Crysvita | Burosumab-twza | Burosumab-twza | Crysvita | 4/17/2018 | ||
| 2018 | 7 | Tavalisse | Fostamatinib | Fostamatinib | Tavalisse | 4/17/2018 | ||
| 2018 | 6 | Ilumya | Tildrakizumab | Tildrakizumab | Ilumya | 3/20/2018 | ||
| 2018 | 5 | Trogarzo | Ibalizumab-uiyk | Ibalizumab-uiyk | Trogarzo | 3/6/2018 | ||
| 2018 | 4 | Erleada | Apalutamide | Apalutamide | Erleada | 2/14/2018 | ||
| 2018 | 3 | Symdeko | Tezacaftor/ivacaftor | Tezacaftor/ivacaftor | Symdeko | 2/12/2018 | ||
| 2018 | 2 | Biktarvy | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate | Biktarvy | 2/7/2018 | ||
| 2018 | 1 | Lutathera | Lutetium lu 177 dotatate | Lutetium lu 177 dotatate | Lutathera | 1/26/2018 |